ADVIA Centaur and ADVIA Centaur XP 를 위한 안전성 경고 / 현장 안전성 서한

Medicines and Healthcare products Regulatory Agency에 따르면, 해당 안전성 경고 / 현장 안전성 서한 는 United Kingdom 에서 Siemens Healthcare Diagnostics Inc 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

현장 안전성 서한은 의료기기 제조사 또는 제조사 대리인이 시중에 유통되고 있는 자사 의료기기 제품에 대하여 취할 수 있는 조치를 알리는 소통방식입니다. 주요 대상층은 보건의료업계 종사자와 의료기기 사용자들입니다. 여기에는 회수(recall) 조치와 경고도 포함될 수 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert / Field Safety Notice
  • 사례 ID
    MDA/2013/005
  • 사례 연번
    CON236897
  • 날짜
    2013-02-14
  • 사례 출판 날짜
    2013-02-14
  • 사례 국가
  • 사례 출처
    MHRA
  • 사례 출처 URL
  • 비고 / 경고
    Data from the United Kingdom is current through April 2019. All of the data comes from the Medicines and Healthcare products Regulatory Agency, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and the United Kingdom.
  • 데이터 추가 비고
  • 원인
    A failure of the wash interconnect circuit board on the advia centaur and advia centaur xp analysers may produce the following errors: 1. failure to detect that the ‘wash 1’ bottle is empty. this could result in credible but erroneous results reported on a number of tests. see affected assays listed below. or 2. incorrect indication that the ‘wash 1’ bottle is empty when actually full, causing the system to stop processing samples. siemens is planning software and hardware updates to resolve these issues by the end of march 2013. the table below summarises the assays affected and what the potential effect is for each. assay type assay potential effect on assay results auto-immune ana false positive or negative bone vitd false positive or negative cardiovascular bnp, high bias ddimer, false positive or negative tniultra always elevated torch and special id rubg2, false positive or negative rubm, false positive or negative toxg, false positive toxm false positive reproductive endocrinology dheas, false positive or negative ee2, false positive or negative shbg false positive or negative infectious disease ahavm, false positive ahavt/havt, low bias ahbcm, false negative ahbct/hbct, false negative ahbe, high or low bias ahbs, false positive ahbs, false positive ahbs2, false positive or negative ahcv, false positive or negative chiv, false positive or negative cmvg, false positive or negative conf, false positive or negative ehiv, false positive hbeag, false positive hbs, false positive hiv, false positive or negative pct, false positive or negative syph false positive or negative immunosuppressant csa low bias liver fibrosis ha,  false positive or negative piinp, false positive or negative timp1 false positive or negative tumour markers / oncology ca153, false positive ca19-9, false positive ca199a, false positive or negative freepsa false positive or negative thyroid tsh3ul false positive or negative.
  • 조치
    Identify if you have affected devices. Follow the manufacturer’s recommendations in the FSN to: Monitor ‘Wash 1’ fluid levels manually. Replace the ‘Wash 1’ bottle before the fluid is depleted. Clear incorrect status or error messages that prohibit testing. Contrary to the manufacturer’s FSN, consider the need to review previous results.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Laboratory analysers for a variety of tests including HIV, tumour markers and hepatitis. Specific assays. Laboratory analysers: ADVIA Centaur ® and ADVIA Centaur ® XP. Specific catalogue numbers. The following assay systems are affected by this alert: ADVIA Centaur system (Cat. 078-A001-xx) ADVIA Centaur refurbished (Cat. 078-A002R02) ADVIA Centaur XP system (Cat. 078-A011-03) ADVIA Centaur XP refurbished (Cat 078-A011R03)
  • Manufacturer

Manufacturer